[go: up one dir, main page]

NO820112L - Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater

Info

Publication number
NO820112L
NO820112L NO820112A NO820112A NO820112L NO 820112 L NO820112 L NO 820112L NO 820112 A NO820112 A NO 820112A NO 820112 A NO820112 A NO 820112A NO 820112 L NO820112 L NO 820112L
Authority
NO
Norway
Prior art keywords
pyridoindol
derivatives
procedure
preparation
therapeutic active
Prior art date
Application number
NO820112A
Other languages
English (en)
Other versions
NO159090C (no
NO159090B (no
Inventor
Willard Mckowan Welch
Charles Armon Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO820112L publication Critical patent/NO820112L/no
Priority to NO871349A priority Critical patent/NO160443C/no
Publication of NO159090B publication Critical patent/NO159090B/no
Publication of NO159090C publication Critical patent/NO159090C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO820112A 1981-01-16 1982-01-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater. NO159090C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO871349A NO160443C (no) 1981-01-16 1987-03-31 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/225,569 US4337250A (en) 1979-07-30 1981-01-16 Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents

Publications (3)

Publication Number Publication Date
NO820112L true NO820112L (no) 1982-07-19
NO159090B NO159090B (no) 1988-08-22
NO159090C NO159090C (no) 1988-11-30

Family

ID=22845384

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820112A NO159090C (no) 1981-01-16 1982-01-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.

Country Status (27)

Country Link
US (1) US4337250A (no)
EP (1) EP0060610B1 (no)
JP (2) JPS57139078A (no)
KR (1) KR860001819B1 (no)
AR (1) AR230283A1 (no)
AT (1) ATE15372T1 (no)
AU (1) AU528710B2 (no)
CA (1) CA1177830A (no)
CS (1) CS248020B2 (no)
DD (3) DD211348A5 (no)
DE (1) DE3265922D1 (no)
DK (1) DK15282A (no)
EG (1) EG15796A (no)
ES (11) ES8304966A1 (no)
FI (1) FI71936C (no)
GR (1) GR74757B (no)
HU (1) HU189090B (no)
IE (1) IE51954B1 (no)
IL (1) IL64774A (no)
NO (1) NO159090C (no)
NZ (1) NZ199473A (no)
PH (1) PH19614A (no)
PL (2) PL138924B1 (no)
PT (1) PT74283A (no)
SU (2) SU1179930A3 (no)
YU (1) YU45854B (no)
ZA (1) ZA82264B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4732984A (en) * 1985-10-17 1988-03-22 American Home Products Corporation Piperazinoisothiazolones with psychotropic activity
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
JPH01140486A (ja) * 1987-11-27 1989-06-01 Hitachi Ltd ブロッホラインメモリ駆動回路
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
TW470745B (en) * 1996-05-23 2002-01-01 Janssen Pharmaceutica Nv Hexahydro-pyrido[4,3-b]indole derivatives
US5879444A (en) * 1997-09-02 1999-03-09 Bayer Corporation Organic pigment compositions
EP1414819B1 (en) 2001-08-08 2005-10-12 Pharmacia & Upjohn Company LLC THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (no) * 1974-03-20 1975-10-04
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler
US4224329A (en) * 1979-01-23 1980-09-23 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
US4252811A (en) * 1979-07-30 1981-02-24 Pfizer Inc. Hexahydro-trans-pyridoindole neuroleptic agents

Also Published As

Publication number Publication date
ES8401965A1 (es) 1984-01-01
ES518291A0 (es) 1984-06-16
ES518295A0 (es) 1984-01-01
NO159090C (no) 1988-11-30
JPS57139078A (en) 1982-08-27
YU9882A (en) 1986-04-30
FI71936C (fi) 1987-03-09
ES8401963A1 (es) 1984-01-01
ES8404851A1 (es) 1984-05-16
ES518294A0 (es) 1984-05-16
ES518296A0 (es) 1984-01-01
ES8401964A1 (es) 1984-01-01
FI820138L (fi) 1982-07-17
DK15282A (da) 1982-08-27
DD208980A5 (de) 1984-04-18
CS248020B2 (en) 1987-01-15
US4337250A (en) 1982-06-29
ES508809A0 (es) 1983-03-16
ES8401962A1 (es) 1984-01-01
PL137682B1 (en) 1986-07-31
ES518289A0 (es) 1984-05-16
AU528710B2 (en) 1983-05-12
GR74757B (no) 1984-07-11
KR860001819B1 (ko) 1986-10-24
ATE15372T1 (de) 1985-09-15
ES8405002A1 (es) 1984-05-16
ES518292A0 (es) 1984-01-01
JPS6130674B2 (no) 1986-07-15
ES518297A0 (es) 1984-06-01
EG15796A (en) 1986-12-30
SU1152522A3 (en) 1985-04-23
ES518293A0 (es) 1984-06-16
DE3265922D1 (en) 1985-10-10
ES518288A0 (es) 1984-01-01
PL138924B1 (en) 1986-11-29
IE820061L (en) 1982-07-16
EP0060610A1 (en) 1982-09-22
PH19614A (en) 1986-05-30
ES8405003A1 (es) 1984-05-16
PL235180A1 (en) 1983-11-21
AU7955282A (en) 1982-07-22
YU45854B (sh) 1992-09-07
ES8405391A1 (es) 1984-06-01
AR230283A1 (es) 1984-03-01
DD222027A5 (de) 1985-05-08
NZ199473A (en) 1985-10-11
IE51954B1 (en) 1987-04-29
IL64774A (en) 1985-06-30
ES8405617A1 (es) 1984-06-16
JPS60185780A (ja) 1985-09-21
ZA82264B (en) 1982-12-29
PT74283A (pt) 1982-02-01
ES8405785A1 (es) 1984-06-16
SU1179930A3 (ru) 1985-09-15
KR830009095A (ko) 1983-12-17
CA1177830A (en) 1984-11-13
ES518290A0 (es) 1984-05-16
IL64774A0 (en) 1982-03-31
NO159090B (no) 1988-08-22
FI71936B (fi) 1986-11-28
DD211348A5 (de) 1984-07-11
ES8304966A1 (es) 1983-03-16
EP0060610B1 (en) 1985-09-04
HU189090B (en) 1986-06-30
PL241179A1 (en) 1984-03-26

Similar Documents

Publication Publication Date Title
NO841568L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO820479L (no) Fremgangsmaate for fremstilling av terapeutisk aktive carbostyrilderivater
NO843979L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO851695L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater
NO821085L (no) Fremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO814136L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO843084L (no) Fremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater
NO841542L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO854369L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO820112L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
NO843377L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater
NO813821L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater
NO813263L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater
NO834437L (no) Fremgangsmaate for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO832430L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyre-derivater